Incyte Corporation INCY
NASDAQ · United States · Health Technology
$121.35-1.85 (-1.50%)
Market closed· · USD · Data may be delayed
Prices may be delayed and are for informational purposes only - not investment advice.
Market closed· · USD · Data may be delayed
Prices may be delayed and are for informational purposes only - not investment advice.
| Quarter | Report date | Actual EPS | Estimated EPS | EPS surprise | Actual revenue | Revenue surprise | Price reaction |
|---|---|---|---|---|---|---|---|
| Q2 2026 | 2026-07-28 | 3.09 | 2.20 | +40.7% | $1.67B | +11.3% | +6.9%$118.87→$127.10 |
| Q1 2026 | 2026-04-28 | 1.81 | 1.34 | +35.1% | — | — | +3.5%$95.72→$99.10 |
| Q4 2025 | 2026-02-10 | 1.80 | 1.92 | -6.2% | — | — | -9.3%$109.03→$98.84 |
| Q3 2025 | 2025-10-28 | 2.26 | 1.64 | +37.8% | — | — | -3.1%$93.08→$90.18 |
| Q2 2025 | 2025-07-29 | 1.57 | 1.47 | +6.8% | — | — | — |
| Q1 2025 | 2025-04-29 | 1.16 | 1.03 | +12.6% | — | — | — |
| Q4 2024 | 2025-02-10 | 1.43 | 1.55 | -7.7% | — | — | — |
| Q3 2024 | 2024-10-29 | 1.07 | 1.09 | -1.8% | — | — | — |
The price reaction is the change from the last close before the announcement date to the first close after it - the report may land before the open, during the session or after the close, so this window covers all three. Not investment advice.